logo

TNON

Tenon Medical·NASDAQ
--
--(--)
--
--(--)
0.94 / 10
Underperform

Evaluation yields 0.9/10, reflecting poor financial health. Key positives: Profit-MV and Net income-Revenue, balanced by issues in Cash-MV and ROA (%). This configuration appears constrained.

Fundamental(0.94)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-0.74
Score3/3
Weight-4.84%
1M Return1.11%
ROA (%)
Value-96.23
Score0/3
Weight19.20%
1M Return-7.20%
Net cash flow from operating activities / Operating revenue (%)
Value-345.96
Score0/3
Weight17.19%
1M Return-6.20%
Profit-MV
Value0.47
Score2/3
Weight-13.87%
1M Return2.92%
Net income-Revenue
Value-0.15
Score2/3
Weight8.64%
1M Return-2.32%
Cash-UP
Value-0.05
Score2/3
Weight15.21%
1M Return-4.39%
Annualized net profit margin on total assets (%)
Value-128.31
Score0/3
Weight19.20%
1M Return-7.20%
Asset-MV
Value-0.51
Score0/3
Weight13.92%
1M Return-3.74%
Cash-MV
Value-0.07
Score1/3
Weight16.75%
1M Return-5.27%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight8.60%
1M Return-2.49%
Is TNON undervalued or overvalued?
  • TNON scores 0.94/10 on fundamentals and holds a Premium valuation at present. Backed by its -180.59% ROE, -396.26% net margin, -0.58 P/E ratio, 1.55 P/B ratio, and 124.36% earnings growth, these metrics solidify its Underperform investment rating.